Heath-Chiozzi Margo
- SEC CIK
- 0001718112
No open-market purchases or sales filed in the past year.
Current role at each company
- CLDX Celldex Therapeutics, Inc.SVP OF REGULATORY AFFAIRSas of Jun 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Heath-Chiozzi Margo as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS | SSale | −58.4K | $33.65 | −$1.96M | −81.3%13.4K after | |
| Jun 3, 2024 (view filing) | May 30 | 4 days | Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS | SSale | −38.7K | $34.07 | −$1.32M | −84.5%7.09K after | |
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Heath-Chiozzi MargoSVP of Regulatory Affairs | SSale | −600 | $40.00 | −$24.0K | −5.1%11.2K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Heath-Chiozzi MargoSVP of Regulatory Affairs | SSale | −600 | $41.71 | −$25.0K | −5.1%11.2K after |